Morgan Stanley Novo Cure LTD Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Novo Cure LTD stock. As of the latest transaction made, Morgan Stanley holds 610,996 shares of NVCR stock, worth $7.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
610,996
Previous 608,126
0.47%
Holding current value
$7.36 Million
Previous $18.1 Million
39.92%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding NVCR
# of Institutions
262Shares Held
79.3MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$146 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$135 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$108 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$66.5 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$62.8 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.26B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...